Jianzhijia Pharmaceutical Chain Group Yönetim

Yönetim kriter kontrolleri 4/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Bo Lan

İcra Kurulu Başkanı

CN¥816.6k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	23.3%
Yönetim ortalama görev süresi	3.8yrs
Yönetim Kurulu ortalama görev süresi	3.9yrs

Son yönetim güncellemeleri

Recent updates

CEO

Bo Lan (57 yo)

no data

Görev süresi

CN¥816,600

Tazminat

Mr. Bo Lan serves as Chairman of the Board and General Manager at Jianzhijia Pharmaceutical Chain Group Co., Ltd. (formerly known as Yunnan Jianzhijia Health-Chain Co., Ltd.).

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Bo Lan	Chairman & GM	no data	CN¥816.60k	23.32% CN¥ 961.7m
Heng Li	CFO, Deputy GM	no data	CN¥464.50k	0.036% CN¥ 1.5m
Yanyin Jiang	Deputy General Manager	3.8yrs	CN¥502.40k	0.17% CN¥ 7.0m
Yanchun Shi	Deputy General Manager	3.8yrs	CN¥818.30k	0.16% CN¥ 6.6m
Yuming Hu	Deputy General Manager	3.8yrs	CN¥254.60k	0.022% CN¥ 893.5k
Fei Yang	Deputy General Manager	1.6yrs	CN¥400.90k	0.026% CN¥ 1.1m
Zhiqi Chai	Deputy General Manager	1.6yrs	CN¥399.50k	0.042% CN¥ 1.7m
Xuejin Song	Accounting Supervisor	no data	Veri yok	Veri yok

3.8yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: 605266 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Bo Lan	Chairman & GM	no data	CN¥816.60k	23.32% CN¥ 961.7m
Heng Li	CFO, Deputy GM	no data	CN¥464.50k	0.036% CN¥ 1.5m
Yumei Jin	Chairman of the Supervisory Board	3.9yrs	Veri yok	0.0071% CN¥ 291.5k
Yunhong Guan	Independent Director	3.9yrs	CN¥120.00k	Veri yok
Li Sun	Supervisor	3.9yrs	Veri yok	0.0091% CN¥ 373.6k
Li Fang	Supervisor	3.9yrs	Veri yok	0.0045% CN¥ 185.1k
Weiwen Zhu	Director	3.9yrs	CN¥120.00k	Veri yok
Liru Yu	Director	3.9yrs	CN¥120.00k	Veri yok
Fangruo Chen	Independent Director	3.9yrs	CN¥120.00k	Veri yok
Zhenji Zhao	Independent Director	3.9yrs	CN¥120.00k	Veri yok

3.9yrs

Ortalama Görev Süresi

52.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 605266 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).

Jianzhijia Pharmaceutical Chain Group Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Jianzhijia Pharmaceutical Chain Group Co., Ltd., Annual General Meeting, May 17, 2024

Jianzhijia Pharmaceutical Chain Group Co., Ltd., Annual General Meeting, May 17, 2024

Less than half of directors are independent

No independent directors

Recent updates

Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) announces an Equity Buyback for CNY 100 million worth of its shares.

Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) announces an Equity Buyback for CNY 100 million worth of its shares.

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Third quarter 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.78 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Jianzhijia Pharmaceutical Chain Group Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) announces an Equity Buyback for 1,006,711 shares, representing 0.64% for CNY 30 million.

Investor sentiment improves as stock rises 23%

New minor risk - Profit margin trend

Second quarter 2024 earnings released: EPS: CN¥0.069 (vs CN¥0.53 in 2Q 2023)

Investor sentiment deteriorates as stock falls 16%

Jianzhijia Pharmaceutical Chain Group Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) announces an Equity Buyback for CNY 30 million worth of its shares.

Jianzhijia Pharmaceutical Chain Group Co., Ltd., Annual General Meeting, May 17, 2024

First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.59 in 1Q 2023)

Jianzhijia Pharmaceutical Chain Group Co., Ltd., Annual General Meeting, May 17, 2024

Jianzhijia Pharmaceutical Chain Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 15%

Jianzhijia Pharmaceutical Chain Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: EPS: CN¥0.94 (vs CN¥0.81 in 3Q 2022)

New minor risk - Financial position

First quarter 2023 earnings released: EPS: CN¥0.77 (vs CN¥0.33 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥1.06 (vs CN¥0.82 in 3Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.94 in 1Q 2021)

No independent directors

Investor sentiment improved over the past week

Yunnan Jianzhijia Health-Chain Co., Ltd. announced that it expects to receive CNY 419.999981 million in funding from Yunnan Xiangqun Investment Co., Ltd

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş